×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 5 - What is “Selected Medical Institution”? - For International Competitiveness Improvement
Session Chair(s)
Toshiya Hara
Executive Vice President
I'ROM GROUP Co., Ltd., Japan
Akiko Kitagawa
President
Kitaris Co., Ltd., Japan
Speaker(s)
Practical Issues, Solutions and Future Perspectives on Early Phase Global Study Operations (Investigator’s Viewpoint)
Toshio Shimizu, MD, PhD
National Cancer Center Hospital, Japan
Head of Physician (Oncology Phase 1 Unit), Dept of Experimental Therapeutics
From a Medical Institution Standpoint
Noriko Morishita, MSN
National Hospital Organization Headquarters, Japan
Manager, Clinical Trial Promotion Office
Challenges of Japanese Clinical Research Site from both ”The Site and The Sponsor” Perspectives
Toshiko Ishibashi, PhD, RN
Daiichi Sankyo Co., Ltd., Japan
Oncology Medical Science Department, Medical Affairs Division
Have an account?